Hangzhou Coco Healthcare Products Co.,Ltd. (SHE:301009)
China · Delayed Price · Currency is CNY 9.83
-0.16 (-1.60%)
May 27, 2026, 3:04 PM CST
SHE:301009 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Net Income | 19.41 | 36.12 | 31.17 | 20.18 | -43.13 | 39.75 |
Depreciation & Amortization | 61.6 | 61.6 | 58.57 | 56.84 | 61.25 | 49.43 |
Other Amortization | 4.86 | 4.86 | 4.61 | 4.78 | 5.53 | 5.34 |
Loss (Gain) From Sale of Assets | 0.1 | 0.1 | 0.04 | 0.1 | -0.12 | -0.04 |
Asset Writedown & Restructuring Costs | 0.01 | 0.01 | 0.21 | 13.86 | 62.3 | 0.16 |
Loss (Gain) From Sale of Investments | -11.42 | -11.42 | 0.38 | 3.34 | -0.24 | -5.05 |
Provision & Write-off of Bad Debts | -0.71 | -0.71 | 0.84 | -3.48 | 5.21 | -2.07 |
Other Operating Activities | 26.73 | 31.91 | 5.31 | 2.08 | -17.27 | 16.79 |
Change in Accounts Receivable | 28.17 | 28.17 | -44.84 | 55.6 | -30.95 | 114.13 |
Change in Inventory | -10.24 | -10.24 | -39.46 | 57.89 | -40.23 | -34.04 |
Change in Accounts Payable | -13.05 | -13.05 | 36.94 | 18.38 | -33.46 | -137.69 |
Operating Cash Flow | 104.86 | 126.76 | 52.44 | 227.7 | -37.2 | 50.53 |
Operating Cash Flow Growth | 54.49% | 141.71% | -76.97% | - | - | -87.24% |
Capital Expenditures | -67.42 | -39.88 | -75.35 | -66.01 | -116.4 | -240.45 |
Sale of Property, Plant & Equipment | 0.07 | 0.06 | 4.44 | 0.69 | 0.61 | 0.47 |
Investment in Securities | 20 | 60 | -260 | -10.56 | - | 120 |
Other Investing Activities | 4.44 | 5.06 | 2.44 | 2.64 | 3.65 | 5.06 |
Investing Cash Flow | -42.91 | 25.24 | -328.47 | -73.25 | -112.14 | -114.92 |
Short-Term Debt Issued | - | 348.94 | 100.01 | 3.05 | - | 50 |
Total Debt Issued | 408.94 | 348.94 | 100.01 | 3.05 | - | 50 |
Short-Term Debt Repaid | - | -249.25 | - | - | - | -149.1 |
Long-Term Debt Repaid | - | -3.32 | -4.26 | -2.76 | -0.84 | -2.25 |
Total Debt Repaid | -352.57 | -252.57 | -4.26 | -2.76 | -0.84 | -151.35 |
Net Debt Issued (Repaid) | 56.37 | 96.37 | 95.74 | 0.3 | -0.84 | -101.35 |
Issuance of Common Stock | - | - | - | - | - | 761.55 |
Repurchase of Common Stock | - | - | -49.69 | - | - | - |
Common Dividends Paid | -20.18 | -20.23 | -20.14 | - | -19.03 | -0.88 |
Other Financing Activities | 29.88 | 31.25 | 1.16 | 0.1 | -30 | 24.5 |
Financing Cash Flow | 66.07 | 107.39 | 27.07 | 0.4 | -49.87 | 683.82 |
Foreign Exchange Rate Adjustments | -21.28 | -11.59 | 6.21 | 2.14 | 4.24 | -2.65 |
Net Cash Flow | 106.75 | 247.8 | -242.75 | 156.99 | -194.97 | 616.78 |
Free Cash Flow | 37.44 | 86.88 | -22.91 | 161.69 | -153.6 | -189.92 |
Free Cash Flow Growth | 200.32% | - | - | - | - | - |
Free Cash Flow Margin | 3.22% | 7.55% | -2.12% | 14.95% | -12.95% | -16.01% |
Free Cash Flow Per Share | 0.14 | 0.34 | -0.09 | 0.56 | -0.57 | -0.81 |
Cash Income Tax Paid | - | -12.26 | -25.17 | -12.13 | -60.14 | -10.59 |
Levered Free Cash Flow | -7.24 | 34.82 | -36.99 | 131.04 | -266.81 | -285.95 |
Unlevered Free Cash Flow | -5.56 | 36.23 | -36.54 | 131.44 | -266.64 | -285.35 |
Change in Working Capital | 4.28 | 4.28 | -48.67 | 129.99 | -110.75 | -53.78 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.